Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rabbee

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Statistical Methods in Medical Research|March 6, 2003
Power and sample size for ordered categorical dataN Rabbee, B A Coull, C Mehta, et al.
Genes, Brain, and Behavior|January 27, 2006
A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in miceD J Speca, N Rabbee, D Chihara, et al.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical TrialM Moline, S Thein, M Bsharat, et al.
Lupus|December 1, 2009
Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosusG W Tew, N Rabbee, K Wolslegel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Statistical Methods in Medical Research|March 6, 2003
Power and sample size for ordered categorical dataN Rabbee, B A Coull, C Mehta, et al.
Genes, Brain, and Behavior|January 27, 2006
A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in miceD J Speca, N Rabbee, D Chihara, et al.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical TrialM Moline, S Thein, M Bsharat, et al.
Lupus|December 1, 2009
Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosusG W Tew, N Rabbee, K Wolslegel, et al.
Pageof 1